Latest Cancer News

Bayer and Orion Initiate Phase III Trial of Novel Prostate Cancer Agent ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (09-18-2014)
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational novel oral androgen receptor... Continue Reading

Breast Conservation Therapy May Be Better than a Mastectomy (09-17-2014)
Breast cancer claims the lives of approximately 40,000 women annually in the United States alone. Early-stage breast cancer refers to cancer that has not spread from its site of origin. Patients with early-stage... Continue Reading

Vaccine Derived from HER2 Protein May Help Prevent Breast Cancer Recurrence (09-16-2014)
A new breast cancer vaccine that is derived from the HER2 protein may help prevent recurrence in patients with HER2-positive disease and appears safe. Phase II study results of the vaccine were released... Continue Reading

More Cancer News

Patient Resources

CoC Logo 541 ACCREDITED PROGRAM caps